Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J M Scheiman

Showing results (1-10 of 74) with videos related to

Pageof 8
Sort By:
Seminars in Arthritis and Rheumatism|February 1, 1992
Pathogenesis of gastroduodenal injury due to nonsteroidal antiinflammatory drugs: implications for prevention and therapyJ M Scheiman
Digestive Diseases (Basel, Switzerland)|July 1, 1994
NSAID-induced peptic ulcer disease: a critical review of pathogenesis and managementJ M Scheiman
Gastroenterology Clinics of North America|June 1, 1996
NSAIDs, gastrointestinal injury, and cytoprotectionJ M Scheiman
The American Journal of Managed Care|February 28, 2001
The impact of nonsteroidal anti-inflammatory drug-induced gastropathyJ M Scheiman
Seminars in Arthritis and Rheumatism|December 22, 2000
Nonsteroidal anti-inflammatory drug gastropathy at the new millennium: mechanisms and preventionM Rich, J M Scheiman
The American Journal of Medicine|February 13, 2001
Prospects for changing the burden of nonsteroidal anti-inflammatory drug toxicityM R Griffin, J M Scheiman
Seminars in Arthritis and Rheumatism|October 1, 1990
Gastroduodenal mucosal damage with salsalate versus aspirin: results of experimental models and endoscopic studies in humansJ M Scheiman, G H Elta
Comprehensive Therapy|January 1, 1994
CholestasisJ M Scheiman, R H Moseley
The American Journal of Medicine|February 15, 2001
The economic implications of cyclooxygenase-2-specific inhibitorsP M Peloso, J M Scheiman
Current Rheumatology Reports|April 5, 2001
Helicobacter pylori and NSAID gastropathy: an ambiguous associationA M Fendrick, J M Scheiman
Pageof 8

Showing results (1-10 of 74) with videos related to

Sort By:
Pageof 8
Seminars in Arthritis and Rheumatism|February 1, 1992
Pathogenesis of gastroduodenal injury due to nonsteroidal antiinflammatory drugs: implications for prevention and therapyJ M Scheiman
Digestive Diseases (Basel, Switzerland)|July 1, 1994
NSAID-induced peptic ulcer disease: a critical review of pathogenesis and managementJ M Scheiman
Gastroenterology Clinics of North America|June 1, 1996
NSAIDs, gastrointestinal injury, and cytoprotectionJ M Scheiman
The American Journal of Managed Care|February 28, 2001
The impact of nonsteroidal anti-inflammatory drug-induced gastropathyJ M Scheiman
Seminars in Arthritis and Rheumatism|December 22, 2000
Nonsteroidal anti-inflammatory drug gastropathy at the new millennium: mechanisms and preventionM Rich, J M Scheiman
The American Journal of Medicine|February 13, 2001
Prospects for changing the burden of nonsteroidal anti-inflammatory drug toxicityM R Griffin, J M Scheiman
Seminars in Arthritis and Rheumatism|October 1, 1990
Gastroduodenal mucosal damage with salsalate versus aspirin: results of experimental models and endoscopic studies in humansJ M Scheiman, G H Elta
Comprehensive Therapy|January 1, 1994
CholestasisJ M Scheiman, R H Moseley
The American Journal of Medicine|February 15, 2001
The economic implications of cyclooxygenase-2-specific inhibitorsP M Peloso, J M Scheiman
Current Rheumatology Reports|April 5, 2001
Helicobacter pylori and NSAID gastropathy: an ambiguous associationA M Fendrick, J M Scheiman
Pageof 8